Investing Profile
Brent Ahrens
Your Intro Paths to Brent Ahrens
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Brent Ahrens on
cbCurrent Investing Position
Canaan Partners General Partner
Investment Range
$250K - $20.0M
Sweet Spot
$10.0M
Investments On Record
45
Current Fund Size
$800M
Brent Ahrens is on these Sector & Stage Rankings
Pharmaceuticals (Seed)Pharmaceuticals (Series A)Pharmaceuticals (Seed)Pharmaceuticals (Series A)Health & Hospital Services (Series A)Health & Hospital Services (Seed)Health IT (Series A)Health IT (Seed)Health & Hospital Services (Series A)Health & Hospital Services (Seed)Health IT (Series A)Health IT (Seed)San Francisco Bay Area
Brent Ahrens's Investments On Record (15)
Company | StageDateRound Size | Total Raised |
---|---|---|
Grey Wolf Therapeutics | Series BJan 2023$49M Series AJan 2020$3M Series AFeb 2019$13M | $65M |
Relievant Medsystems | Series UnknownOct 2020$70M Series EJun 2018$58M Series DOct 2016$36M Series DMar 2012$30M Series CJul 2009$20M Series BOct 2006$5M | $220M |
EndoGastric Solutions | Series IJun 2018$41M Series UnknownDec 2015$50M Series GMay 2014$30M Series UnknownJun 2012$13M Series UnknownApr 2012$2M Series GMar 2012$11M Series FAug 2010$30M | $230M |
Unchained Labs | Series DMar 2018$17M Series CJun 2017$13M Series BFeb 2016$25M Series AFeb 2015$25M | $80M |
Iterum Therapeutics | Series BMay 2017$65M Series AMar 2016$40M | $110M |
Abyrx | Series UnknownDec 2016$10M | $10M |
Minimally invasive devices | Series CNov 2015$14M Debt FinancingJun 2014$6M Series BJun 2013$3M Series BMar 2013$9M | $32M |
Spinifex Pharmaceuticals | Series CApr 2014$45M | $66M |
Investors who invest with Brent Ahrens